Skip to main content
Rena Patel, MD, Infectious Disease, Birmingham, AL

Rena Chiman Patel MD


Clinical Fellow, Internal Medicine, UCSF School of Medicine

Join to view full profile
  • 619 19th St SBirmingham, AL 35233

  • Phone+1 205-934-4011

Join Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Rena Patel, MD is an infectious disease specialist in Birmingham, Alabama. She is currently licensed to practice medicine in Alabama, Washington, and California. She is affiliated with University of Alabama Hospital and is a Clinical Fellow at UCSF School of Medicine.

Education & Training

  • Loma Linda University Health Education Consortium
    Loma Linda University Health Education ConsortiumResidency, Gastroenterology, 2016 - 2022
  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Infectious Disease, 2012 - 2014
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 2009

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - Present
  • AL State Medical License
    AL State Medical License 2023 - 2026
  • WA State Medical License
    WA State Medical License 2015 - 2024
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • Association Between Immune Dysfunction, Breakthrough Covid Infection After Vaccination
    Association Between Immune Dysfunction, Breakthrough Covid Infection After VaccinationDecember 29th, 2021

Grant Support

  • A tale of two cities: Understanding geographic differences by region and rurality in HIV care outcomes in the U.S.UNIVERSITY OF ALABAMA AT BIRMINGHAM2022–2027
  • Co-benefits of co-delivery of long-acting antiretrovirals and contraceptivesUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2027